170 related articles for article (PubMed ID: 16520355)
1. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma.
Choi BO; Jang HS; Kang KM; Lee SW; Kang YN; Chai GY; Choi IB
Jpn J Clin Oncol; 2006 Mar; 36(3):154-8. PubMed ID: 16520355
[TBL] [Abstract][Full Text] [Related]
2. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
4. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
5. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas.
Selch MT; Ahn E; Laskari A; Lee SP; Agazaryan N; Solberg TD; Cabatan-Awang C; Frighetto L; Desalles AA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):101-11. PubMed ID: 15093905
[TBL] [Abstract][Full Text] [Related]
8. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.
Jang JW; Kay CS; You CR; Kim CW; Bae SH; Choi JY; Yoon SK; Han CW; Jung HS; Choi IB
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):412-8. PubMed ID: 18963538
[TBL] [Abstract][Full Text] [Related]
11. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy for aged patients with hepatocellular carcinoma.
Hata M; Tokuuye K; Sugahara S; Tohno E; Nakayama H; Fukumitsu N; Mizumoto M; Abei M; Shoda J; Minami M; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):805-12. PubMed ID: 17524568
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma.
Kawashima M; Furuse J; Nishio T; Konishi M; Ishii H; Kinoshita T; Nagase M; Nihei K; Ogino T
J Clin Oncol; 2005 Mar; 23(9):1839-46. PubMed ID: 15774777
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
[TBL] [Abstract][Full Text] [Related]
15. Radiation treatment outcomes for unresectable hepatocellular carcinoma.
Skinner HD; Sharp HJ; Kaseb AO; Javle MM; Vauthey JN; Abdalla EK; Delclos ME; Das P; Crane CH; Krishnan S
Acta Oncol; 2011 Nov; 50(8):1191-8. PubMed ID: 21793641
[TBL] [Abstract][Full Text] [Related]
16. Two-week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma.
Park JH; Yoon SM; Lim YS; Kim SY; Shim JH; Kim KM; Lee HC; Cho B; Park G; Kim JH
J Gastroenterol Hepatol; 2013 Oct; 28(10):1638-42. PubMed ID: 23621519
[TBL] [Abstract][Full Text] [Related]
17. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
Hamamoto Y; Niino K; Ishiyama H; Hosoya T
Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis].
Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM
Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma.
Yang ZX; Wang D; Wang G; Zhang QH; Liu JM; Peng P; Liu XH
J Cancer Res Clin Oncol; 2010 Apr; 136(4):625-30. PubMed ID: 19882171
[TBL] [Abstract][Full Text] [Related]
20. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma.
Kim K; Chie EK; Kim W; Kim YJ; Yoon JH; Lee HS; Ha SW
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):729-34. PubMed ID: 20171806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]